Consensus Novartis AG

Equities

Market Closed - Swiss Exchange Other stock markets 11:31:51 2024-04-24 am EDT			5-day change	1st Jan Change
89.12 ^CHF	+0.20%		+4.85%	+5.01%

Apr. 24	BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating	MT
Apr. 24	Novartis Says New Malaria Drug Formulation Safe and Effective for Babies	MT

02.IZezDFgFCsmHHKJxihUS2zCyTvNHGq5gMNBRcylZ_Vs.VNXWVjFpOrrtSuoW_mFDi37gN5dzLvFUfJcdA0NvpQ9rxYRgIjRyk-VXyQ~57e0ad78ff62acfb91bf7663be23df26

BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating	Apr. 24	MT
NOVARTIS AG : UBS reaffirms its Buy rating	Apr. 24	ZD
NOVARTIS AG : Deutsche Bank gives a Buy rating	Apr. 24	ZD
NOVARTIS AG : JP Morgan remains Neutral	Apr. 24	ZD
NOVARTIS : 2024 has started on a strong note; guidance upgraded	Apr. 23
NOVARTIS AG : JP Morgan gives a Neutral rating	Apr. 23	ZD
NOVARTIS AG : Barclays keeps a Sell rating	Apr. 23	ZD
NOVARTIS : Oddo BHF confirms its recommendation on the share	Apr. 23	CF
NOVARTIS AG : UBS remains its Buy rating	Apr. 23	ZD
NOVARTIS AG : Gets a Buy rating from Jefferies	Apr. 23	ZD
Novartis Raises Guidance on Profit, Sales Growth -- Update	Apr. 23	DJ
Novartis Raises Guidance on Profit, Sales Growth	Apr. 23	DJ
NOVARTIS AG : UBS reiterates its Buy rating	Apr. 18	ZD
NOVARTIS AG : Deutsche Bank maintains a Buy rating	Apr. 18	ZD
Trending : Novartis Begins Tender Offer for MorphoSys Shares	Apr. 11	DJ
NOVARTIS : UBS reiterates its recommendation on the stock	Apr. 11	CF
NOVARTIS AG : UBS remains its Buy rating	Apr. 10	ZD
NOVARTIS AG : Jefferies maintains a Buy rating	Apr. 04	ZD
NOVARTIS AG : UBS reiterates its Buy rating	Apr. 04	ZD
NOVARTIS AG : Gets a Neutral rating from JP Morgan	Apr. 03	ZD
NOVARTIS AG : Barclays gives a Sell rating	Mar. 28	ZD
NOVARTIS AG : Berenberg remains Neutral	Mar. 25	ZD
NOVARTIS AG : Buy rating from Deutsche Bank	Mar. 22	ZD
BMO Capital Initiates Novartis at Market Perform Rating With $114 Price Target	Feb. 26	MT
NOVARTIS : Novartis on course to set new highs	Feb. 20

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

97.51 USD

Average target price

108.1 USD

Spread / Average Target

+10.83%

High Price Target

130.7 USD

Spread / Highest target

+34.02%

Low Price Target

81.17 USD

Spread / Lowest Target

-16.75%

DEUTSCHE BANK RESEARCH	Emmanuel Papadakis
alphavalue	Abhishek Raval
JPMORGAN	Richard Vosser
BARCLAYS	Emily Field
UBS	Matthew Weston
JEFFERIES	Peter Welford
BERENBERG	Kerry Holford
BMO Capital
DZ BANK	Elmar Kraus
Kepler Capital Markets
Societe Generale
Redburn
Stifel Nicolaus
BNP Paribas
MORGAN STANLEY	Mark Purcell
Barrington Research
Credit Suisse
International Strategy & Investment Group
Morningstar
ODDO BHF
GOLDMAN SACHS	Keyur Parekh
DA Davidson
Zacks Equity Research
Bank of America Securities/Merrill Lynch
BERNSTEIN RESEARCH	Wimal Kapadia
Kepler Cheuvreux
Wolfe Research
AltaCorp Capital
DEUTSCHE BANK	Emmanuel Papadakis
HSBC
Exane BNP Paribas
Bryan, Garnier & Co.
Berenberg Bank
Deutsche Bank Securities
Moody's Investors Service
Dundee
Exane BNP
Bernstein
Argus
Cowen
BRYAN GARNIER	Eric Le Berrigaud
LIBERUM CAPITAL	Graham Doyle
BANK OF AMERICA (BOFA)	Graham Parry

Trading Rating

Investor Rating

ESG Refinitiv

B-